These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9042977)

  • 21. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
    Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N; Cutler A
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
    Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
    Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.
    Savarino V; Mansi C; Mele MR; Bisso G; Mela GS; Saggioro A; Caroli M; Vigneri S; Termini R; Olivieri A; Tosatto R; Celle G
    Aliment Pharmacol Ther; 1997 Aug; 11(4):699-703. PubMed ID: 9305478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection.
    Marchi S; Costa F; Bellini M; Belcari C; Mumolo MG; Tornar A; Spisni R; Torelli E; Maltinti G
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):547-50. PubMed ID: 11396535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
    Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
    Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Armuzzi A; Gasbarrini A; Pastorelli A; Papa A; Gasbarrini G
    Dig Dis Sci; 1999 Dec; 44(12):2386-9. PubMed ID: 10630486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing.
    Pounder RE; Wyeth JW; Duggan AE; Bailey RJ; Louw JA; Ohlin B
    Helicobacter; 1997 Sep; 2(3):132-9. PubMed ID: 9432341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.
    Kaviani MJ; Malekzadeh R; Vahedi H; Sotoudeh M; Kamalian N; Amini M; Massarrat S
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):915-9. PubMed ID: 11507355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
    Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
    Ricciardiello L; Cannizzaro O; D'Angelo A; Ederle A; Gerace G; Iaquinto G; Reina G; Scarpulla G; Spadaccini A; Olivieri A; Tosatto R; Fossi S; Pozzato P; Zagari M; Bazzoli F; Roda E
    Aliment Pharmacol Ther; 1998 Jun; 12(6):533-7. PubMed ID: 9678812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
    Gisbert JP; Marcos S; Gisbert JL; Pajares JM
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1303-7. PubMed ID: 11692055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
    Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
    Lo WC; Lin HJ; Wang K; Perng CL; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):171-6. PubMed ID: 9198292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication.
    Uygun A; Kadayifci A; Yesilova Z; Ates Y; Safali M; Ilgan S; Bagci S; Dagalp K
    Indian J Gastroenterol; 2007; 26(4):174-7. PubMed ID: 17986746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA; Haeck PW; Otten MH; Mulder CJ
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
    Veldhuyzen van Zanten S; Chiba N; Barkun A; Fallone C; Farley A; Cockeram A; Dallaire C; Simms L; Nicholls B
    Can J Gastroenterol; 2003 Sep; 17(9):533-8. PubMed ID: 14532926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
    Sung JJ; Leung WK; Ling TK; Yung MY; Chan FK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1998 Aug; 12(8):725-30. PubMed ID: 9726384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.